110 related articles for article (PubMed ID: 21251710)
1. Modulation of biological processes in the nucleus by delivery of DNA oligonucleotides conjugated with gold nanoparticles.
Kim DW; Kim JH; Park M; Yeom JH; Go H; Kim S; Han MS; Lee K; Bae J
Biomaterials; 2011 Apr; 32(10):2593-604. PubMed ID: 21251710
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of xenograft tumor growth in mice by gold nanoparticle-assisted delivery of short hairpin RNAs against Mcl-1L.
Ryou SM; Park M; Kim JM; Jeon CO; Yun CH; Han SH; Kim SW; Lee Y; Kim S; Han MS; Bae J; Lee K
J Biotechnol; 2011 Nov; 156(2):89-94. PubMed ID: 21906638
[TBL] [Abstract][Full Text] [Related]
3. Effective delivery of anti-miRNA DNA oligonucleotides by functionalized gold nanoparticles.
Kim JH; Yeom JH; Ko JJ; Han MS; Lee K; Na SY; Bae J
J Biotechnol; 2011 Sep; 155(3):287-92. PubMed ID: 21807040
[TBL] [Abstract][Full Text] [Related]
4. Gold nanoparticle-DNA aptamer composites as a universal carrier for in vivo delivery of biologically functional proteins.
Ryou SM; Yeom JH; Kang HJ; Won M; Kim JS; Lee B; Seong MJ; Ha NC; Bae J; Lee K
J Control Release; 2014 Dec; 196():287-94. PubMed ID: 25450403
[TBL] [Abstract][Full Text] [Related]
5. Factors determining the efficacy of nuclear delivery of antisense oligonucleotides by gold nanoparticles.
Liu Y; Franzen S
Bioconjug Chem; 2008 May; 19(5):1009-16. PubMed ID: 18393455
[TBL] [Abstract][Full Text] [Related]
6. Delivery of shRNA using gold nanoparticle-DNA oligonucleotide conjugates as a universal carrier.
Ryou SM; Kim S; Jang HH; Kim JH; Yeom JH; Eom MS; Bae J; Han MS; Lee K
Biochem Biophys Res Commun; 2010 Jul; 398(3):542-6. PubMed ID: 20599759
[TBL] [Abstract][Full Text] [Related]
7. Modification of alternative splicing of Mcl-1 pre-mRNA using antisense morpholino oligonucleotides induces apoptosis in basal cell carcinoma cells.
Shieh JJ; Liu KT; Huang SW; Chen YJ; Hsieh TY
J Invest Dermatol; 2009 Oct; 129(10):2497-506. PubMed ID: 19369967
[TBL] [Abstract][Full Text] [Related]
8. Combined blockade of protein kinase A and bcl-2 by antisense strategy induces apoptosis and inhibits tumor growth and angiogenesis.
Tortora G; Caputo R; Damiano V; Bianco R; Fontanini G; Cuccato S; De Placido S; Bianco AR; Ciardiello F
Clin Cancer Res; 2001 Aug; 7(8):2537-44. PubMed ID: 11489837
[TBL] [Abstract][Full Text] [Related]
9. A functionalized gold nanoparticles-assisted universal carrier for antisense DNA.
Kim JH; Jang HH; Ryou SM; Kim S; Bae J; Lee K; Han MS
Chem Commun (Camb); 2010 Jun; 46(23):4151-3. PubMed ID: 20454745
[TBL] [Abstract][Full Text] [Related]
10. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
[TBL] [Abstract][Full Text] [Related]
11. CpG immunomer DNA enhances antisense protein kinase A RIalpha inhibition of multidrug-resistant colon carcinoma growth in nude mice: molecular basis for combinatorial therapy.
Nesterova MV; Johnson NR; Stewart T; Abrams S; Cho-Chung YS
Clin Cancer Res; 2005 Aug; 11(16):5950-5. PubMed ID: 16115938
[TBL] [Abstract][Full Text] [Related]
12. Bcl-2 antisense oligonucleotides are effective against systemic but not central nervous system disease in severe combined immunodeficient mice bearing human t(14;18) follicular lymphoma.
Mohammad R; Abubakr Y; Dan M; Aboukameel A; Chow C; Mohamed A; Hamdy N; Al-Katib A
Clin Cancer Res; 2002 Apr; 8(4):1277-83. PubMed ID: 11948143
[TBL] [Abstract][Full Text] [Related]
13. Effects of BCL-2 suppression by antisense oligonucleotides on additional regulators of apoptosis compensatory change in non-targeted protein expression.
Rubenstein M; Hollowell CM; Guinan P
In Vivo; 2011; 25(5):725-32. PubMed ID: 21753125
[TBL] [Abstract][Full Text] [Related]
14. [Effect of ZGDHu-1 on proliferation and apoptosis of A549 cells in vitro and antitumor activity in vivo].
Zhou YL; Hu WX; Lü YP; Qiu LN; Wang WS; Yang ZY; Liu JD; Rao GW
Yao Xue Xue Bao; 2007 Jan; 42(1):26-34. PubMed ID: 17520803
[TBL] [Abstract][Full Text] [Related]
15. Tumor-homing, size-tunable clustered nanoparticles for anticancer therapeutics.
Kim J; Lee YM; Kang Y; Kim WJ
ACS Nano; 2014 Sep; 8(9):9358-67. PubMed ID: 25184691
[TBL] [Abstract][Full Text] [Related]
16. Bcl-2 antisense oligonucleotides chemosensitize human gastric cancer in a SCID mouse xenotransplantation model.
Wacheck V; Heere-Ress E; Halaschek-Wiener J; Lucas T; Meyer H; Eichler HG; Jansen B
J Mol Med (Berl); 2001 Oct; 79(10):587-93. PubMed ID: 11692156
[TBL] [Abstract][Full Text] [Related]
17. Bispecific antisense oligonucleotides have activity comparable to monospecifics in inhibiting expression of BCL-2 in LNCaP cells.
Rubenstein M; Guinan P
In Vivo; 2010; 24(4):489-93. PubMed ID: 20668314
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Xenograft tumor growth by gold nanoparticle-DNA oligonucleotide conjugates-assisted delivery of BAX mRNA.
Yeom JH; Ryou SM; Won M; Park M; Bae J; Lee K
PLoS One; 2013; 8(9):e75369. PubMed ID: 24073264
[TBL] [Abstract][Full Text] [Related]
19. Hybridization of different antisense oligonucleotides on the surface of gold nanoparticles to silence zinc metalloproteinase gene after uptake by Leishmania major.
Jebali A; Anvari-Tafti MH
Colloids Surf B Biointerfaces; 2015 May; 129():107-13. PubMed ID: 25835145
[TBL] [Abstract][Full Text] [Related]
20. Gold nanoparticle-assisted delivery of small, highly structured RNA into the nuclei of human cells.
Ryou SM; Kim JM; Yeom JH; Hyun S; Kim S; Han MS; Kim SW; Bae J; Rhee S; Lee K
Biochem Biophys Res Commun; 2011 Dec; 416(1-2):178-83. PubMed ID: 22093830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
